Molina Healthcare
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Molina Healthcare's revenues will grow 28.6% and EPS will shrink to a loss.
The average estimate for revenue is $1.51 billion. On the bottom line, the average EPS estimate is -$0.11.
Revenue details
Last quarter, Molina Healthcare logged revenue of $1.54 billion. GAAP reported sales were 32% higher than the prior-year quarter's $1.17 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS details
Last quarter, EPS came in at -$0.80. GAAP EPS were -$0.80 for Q2 compared to $0.38 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
Recent performance
For the preceding quarter, gross margin was 10.3%, 840 basis points worse than the prior-year quarter. Operating margin was -3.9%, 660 basis points worse than the prior-year quarter. Net margin was -2.4%, 390 basis points worse than the prior-year quarter.
Looking ahead
The full year's average estimate for revenue is $5.98 billion. The average EPS estimate is -$0.33.
Investor sentiment
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 131 members out of 144 rating the stock outperform, and 13 members rating it underperform. Among 39 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 36 give Molina Healthcare a green thumbs-up, and three give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Molina Healthcare is hold, with an average price target of $27.18.
- Add Molina Healthcare to My Watchlist.